Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
New Jersey Resources
NJR
$5.45B
| $11.6M | 0.02% |
352,104
+202,111
| +135% | +$6.19M |
|
852
Globe Life
GL
$13.3B
| $11.6M | 0.02% |
202,585
-93,477
| -32% | -$5.47M |
|
|
HT
853
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $11.6M | 0.02% |
530,789
-48,005
| -8% | -$1.14M |
|
|
PRAH
854
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.5M | 0.02% |
254,300
+57,697
| +29% | +$2.42M |
|
855
Boise Cascade
BCC
$2.87B
| $11.5M | 0.02% |
449,904
+221,956
| +97% | +$6.34M |
|
|
TWTR
856
DELISTED
Twitter, Inc.
TWTR
| $11.5M | 0.02% |
+496,114
| New | +$13.2M |
|
|
SUNE
857
DELISTED
SUNEDISON, INC COM
SUNE
| $11.4M | 0.02% |
2,246,418
+863,933
| +62% | +$5.3M |
|
858
HEICO Corp
HEI
$49.3B
| $11.4M | 0.02% |
513,442
-396,761
| -44% | -$8.26M |
|
|
INFI
859
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $11.4M | 0.02% |
1,456,285
+1,274,197
| +700% | +$11M |
|
860
Lexicon Pharmaceuticals
LXRX
$1.03B
| $11.3M | 0.02% |
850,407
+531,026
| +166% | +$6.53M |
|
861
Willis Towers Watson
WTW
$32.6B
| $11.3M | 0.02% |
87,936
+41,292
| +89% | +$4.89M |
|
862
CALL
iShares Russell 2000 ETF
IWM
$81.4B
| $11.3M | 0.02% |
100,000
+50,000
| +100% | +$5.77M |
|
|
863
PUT
iShares Russell 2000 ETF
IWM
$81.4B
| $11.3M | 0.02% |
+100,000
| New | +$11.5M |
|
|
XL
864
DELISTED
XL Group Ltd.
XL
| $11.3M | 0.02% |
287,423
-764,687
| -73% | -$29M |
|
|
KTWO
865
DELISTED
K2M Group Holdings, Inc
KTWO
| $11.3M | 0.02% |
570,300
+328,865
| +136% | +$6.39M |
|
866
Essent Group
ESNT
$6.15B
| $11.3M | 0.02% |
514,100
-471,082
| -48% | -$11.4M |
|
867
Unum
UNM
$14.2B
| $11.2M | 0.02% |
337,005
-920,217
| -73% | -$31.7M |
|
|
MACK
868
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $11.2M | 0.02% |
+180,138
| New | +$12.7M |
|
|
SGNT
869
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $11.2M | 0.02% |
703,536
+108,045
| +18% | +$1.7M |
|
|
ESV
870
CALL
DELISTED
Ensco Rowan plc
ESV
| $11.2M | 0.02% |
181,825
| – | – |
|
|
LBMH
871
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $11.2M | 0.02% |
3,338,509
-1,589,191
| -32% | -$4.62M |
|
872
Euronet Worldwide
EEFT
$2.63B
| $11.1M | 0.02% |
+153,810
| New | +$11.8M |
|
873
CALL
Air Products & Chemicals
APD
$68.2B
| $11.1M | 0.02% |
+92,426
| New | +$11.6M |
|
|
RPTP
874
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $11.1M | 0.02% |
2,129,374
+1,429,350
| +204% | +$8.29M |
|
|
FNSR
875
DELISTED
Finisar Corp
FNSR
| $11.1M | 0.02% |
761,147
+303,282
| +66% | +$3.75M |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.